PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
30-Apr-2024 Zomedica to Report First Quarter 2024 Financial Results and Provide Business Update on May 9th at 4:30 p.m. ET AccessWire
30-Apr-2024 NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon AccessWire
30-Apr-2024 Digital Pharmaceutical Supply Chain Management Market Size To Reach $1.84Bn By 2030 Grand View Research
30-Apr-2024 MindBio Therapeutics Announces Landmark Women’s Health CNS Drug Trials AccessWire
30-Apr-2024 Moolec Announces New Patent Granting in the United States for Molecular Farming Platform AccessWire
30-Apr-2024 Watson-Marlow advances its OEM panel mount solution DriveSure with latest technology Watson-Marlow Fluid Technology Solutions
30-Apr-2024 New Immuno-Oncology Research Project in Partnership With Merck Starts at the BioMed X Institute in Heidelberg AccessWire
30-Apr-2024 Poolbeg Pharma PLC Announces Results for the Year Ended 31 December 2023 AccessWire
30-Apr-2024 Bayer and Evotec Collaborate to Advance Precision Cardiology AccessWire
30-Apr-2024 Bayer and Evotec collaborate to advance precision cardiology Evotec SE
30-Apr-2024 Genflow Biosciences PLC Announces Total Voting Rights AccessWire
30-Apr-2024 Poolbeg Pharma PLC Announces Appointment of Joint Broker AccessWire
30-Apr-2024 Poolbeg Pharma PLC Announces Option Agreement to Acquire Orphan Drug Candidate AccessWire
30-Apr-2024 Wearable Sensors Market towards a USD 10.19 Billion by 2032 Wired Release
30-Apr-2024 Relief Therapeutics has Published its Annual Report AccessWire
30-Apr-2024 Relief Therapeutics has published its Annual Report Relief Therapeutics Holding SA
30-Apr-2024 Final allocation of DocMorris CHF 200 million Convertible Bonds Offering DocMorris AG
30-Apr-2024 Newron announces positive top-line results from potentially pivotal Phase II/III study 008A with evenamide in schizophrenia patients Newron Pharmaceuticals S.p.A.
30-Apr-2024 Xlife Sciences AG Reports Strong Portfolio Growth and Strategic Advances in the 2023 Valuation Report Xlife Sciences AG
30-Apr-2024 Straumann Group showed a solid start into 2024, with varied regional growth dynamic Straumann Holding AG